This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tada, Y. Articles by Kuwano, M. Search for Related Content PubMed PubMed Citation Articles by Tada, Y. Articles by Kuwano, M.

The Association of Death-associated Protein Kinase Hypermethylation with Early Recurrence in Superficial Bladder Cancers¹

Departments of Medical Biochemistry [Y. T., M. W., Y. M., M. K.], Anatomical Pathology [K. T., M. T.], Medical Information [N. K.], and Urology [S. N.], Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan

Mechanisms for bladder carcinogenesis and the development of recurrentbladder cancer remain unclear. Aberrant methylation of the 5' CpG island is thought to play an important role in the inactivation of the tumor suppressor genes in cancer. To study whether specific or bulk hypermethylation predicts intrabladder recurrence, we determined the frequency of aberrant promoter hypermethylation of seven genes, hMLH1, O⁶-methylguanine-DNA-methyltransferase (MGMT), p16, Von Hippel-Lindau (VHL), death-associated protein kinase (DAP-kinase), glutathione S-transferase P1 (GST-P1) and E-cadherin in 55 superficial bladder cancers and 5 normal urothelial epithelia by methylation-specific PCR (MSP). These patients of superficial bladder cancer had been followed prospectively by cystoscopy. Simultaneous hypermethylation of three genes or more among the seven genes was observed in 2 (7%) of 30 patients in the nonrecurrence group and 7 (28%) of 25 patients in the recurrence group. There was a significant concordance between the number of methylated genes and the development of recurrence (P = 0.012). In particular, the recurrence rate for 24 months was 88% for hypermethylation of DAP-kinase and 28% for nonmethylation of DAP-kinase. Hypermethylation of DAP-kinase is, therefore, a strong indicator of the superficial bladder cancer associated with a high recurrence rate (P < 0.001; hazards ratio, 7.01). Our results suggest that hypermethylation of DAP-kinase might be a useful prognostic marker for disease recurrence in superficial bladder cancers.

This article has been cited by other articles:

				N. Kholod, J. Boniver, and P. Delvenne A New Dimethyl Sulfoxide-Based Method for Gene Promoter Methylation Detection J. Mol. Diagn., November 1, 2007; 9(5): 574 - 581. [Abstract] [Full Text] [PDF]

				E. Kellen, M. Hemelt, K. Broberg, K. Golka, V. N. Kristensen, R. J. Hung, G. Matullo, R. D. Mittal, S. Porru, A. Povey, et al. Pooled Analysis and Meta-analysis of the Glutathione S-Transferase P1 Ile 105Val Polymorphism and Bladder Cancer: A HuGE-GSEC Review Am. J. Epidemiol., June 1, 2007; 165(11): 1221 - 1230. [Abstract] [Full Text] [PDF]

				F. Christoph, S. Weikert, C. Kempkensteffen, H. Krause, M. Schostak, J. Kollermann, K. Miller, and M. Schrader Promoter Hypermethylation Profile of Kidney Cancer with New Proapoptotic p53 Target Genes and Clinical Implications Clin. Cancer Res., September 1, 2006; 12(17): 5040 - 5046. [Abstract] [Full Text] [PDF]

				Y. Tada, R. M. Brena, B. Hackanson, C. Morrison, G. A. Otterson, and C. Plass Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. J Natl Cancer Inst, March 15, 2006; 98(6): 396 - 406. [Abstract] [Full Text] [PDF]

				W.-J. Kim, E.-J. Kim, P. Jeong, C. Quan, J. Kim, Q.-L. Li, J.-O. Yang, Y. Ito, and S.-C. Bae RUNX3 Inactivation by Point Mutations and Aberrant DNA Methylation in Bladder Tumors Cancer Res., October 15, 2005; 65(20): 9347 - 9354. [Abstract] [Full Text] [PDF]

				K. Miyamoto and T. Ushijima Diagnostic and Therapeutic Applications of Epigenetics Jpn. J. Clin. Oncol., June 1, 2005; 35(6): 293 - 301. [Abstract] [Full Text] [PDF]

				M. G. Friedrich, D. J. Weisenberger, J. C. Cheng, S. Chandrasoma, K. D. Siegmund, M. L. Gonzalgo, M. I. Toma, H. Huland, C. Yoo, Y. C. Tsai, et al. Detection of Methylated Apoptosis-Associated Genes in Urine Sediments of Bladder Cancer Patients Clin. Cancer Res., November 15, 2004; 10(22): 7457 - 7465. [Abstract] [Full Text] [PDF]

				I. J. Schultz, L. A. Kiemeney, H. F.M. Karthaus, J. A. Witjes, J. L. Willems, D. W. Swinkels, J. M.T. K. Gunnewiek, and J. B. de Kok Survivin mRNA Copy Number in Bladder Washings Predicts Tumor Recurrence in Patients with Superficial Urothelial Cell Carcinomas Clin. Chem., August 1, 2004; 50(8): 1425 - 1428. [Full Text] [PDF]

				L. Kopelovich, J. A. Crowell, and J. R. Fay The Epigenome as a Target for Cancer Chemoprevention J Natl Cancer Inst, December 3, 2003; 95(23): 1747 - 1757. [Abstract] [Full Text] [PDF]

				A. N. Reddy, W. W. Jiang, M. Kim, N. Benoit, R. Taylor, J. Clinger, D. Sidransky, and J. A. Califano Death-Associated Protein Kinase Promoter Hypermethylation in Normal Human Lymphocytes Cancer Res., November 15, 2003; 63(22): 7694 - 7698. [Abstract] [Full Text] [PDF]